SCHEMBL796549

SCHEMBL796549

COc1ccc2c(c1)sc1nc(-c3ccc(F)s3)cn12

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.67
TP53 P04637 4/20 0.67
LMNA P02545 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
TSHR P16473 1/20 0.67
RAB9A P51151 1/20 0.67
ATM Q13315 1/20 0.67
TDP1 Q9NUW8 1/20 0.67
APP P05067 2/20 0.61
PARP15 Q460N3 1/20 0.54
PARP10 Q53GL7 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54
PARP2 Q9UGN5 1/20 0.54
RXFP1 Q9HBX9 2/20 0.50
POLB P06746 1/20 0.48
THRB P10828 2/20 0.46
FLT3 P36888 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL796769 0.88 MAPT (0.70) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL13394600 0.85 MAPT (0.67) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL804930 0.85 MAPT (0.67) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL13394267 0.83 MAPT (0.78) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL13394277 0.82 TP53 (0.69) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL13394284 0.82 MAPT (0.72) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL13394520 0.81 TP53 (0.68) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL17129983 0.80 MAPT (0.69) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL13198284 0.80 MAPT (0.69) MAPTTP53LMNASMN1; SMN2TSHR
SCHEMBL11015014 0.80 TP53 (1.00) MAPTTP53LMNASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
WO-2010092111-A2 COMPOUNDS FOR NON-INVASIVE MEASUREMENT OF AGGREGATES OF AMYLOID PEPTIDES Technische Universität München (DE) 2010-08-19 WO disclosed
EP-2218464-A1 Compounds for non-invasive measurement of aggregates of amyloid peptides Technische Universität München (DE) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT MAPT 10/4885TP53 619/4885LMNA 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.